US BANCORP \DE\ - ASTERIAS BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2018$0
-100.0%
6870.0%0.00%
Q3 2018$1,0000.0%6870.0%0.00%
Q2 2018$1,0000.0%6870.0%0.00%
Q1 2018$1,000
-50.0%
6870.0%0.00%
Q4 2017$2,0000.0%6870.0%0.00%
Q3 2017$2,0000.0%6870.0%0.00%
Q2 2017$2,0000.0%6870.0%0.00%
Q1 2017$2,000
-33.3%
6870.0%0.00%
Q4 2016$3,0000.0%6870.0%0.00%
Q3 2016$3,000
+50.0%
6870.0%0.00%
Q2 2016$2,000
-33.3%
6870.0%0.00%
Q1 2016$3,0000.0%6870.0%0.00%
Q4 2015$3,0000.0%6870.0%0.00%
Q3 2015$3,0000.0%6870.0%0.00%
Q2 2015$3,000
-40.0%
6870.0%0.00%
Q1 2015$5,000
+150.0%
6870.0%0.00%
Q4 2014$2,0006870.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$11,907,0001.66%
Northeast Financial Consultants Inc 732,265$1,647,0000.55%
AJ WEALTH STRATEGIES, LLC 29,624$67,0000.02%
Family Management Corp 10,424$23,0000.02%
Virtu Financial LLC 71,588$161,0000.01%
Poehling Capital Management, INC. 2,802$6,0000.01%
Founders Capital Management 2,000$5,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$333,0000.00%
WEDBUSH SECURITIES INC 11,000$25,0000.00%
THRIVENT FINANCIAL FOR LUTHERANS 298,303$671,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders